Fragransin A2 is primarily studied for its potential biological activities, particularly in the field of natural product pharmacology. It has shown notable anti-inflammatory and antioxidant effects in cellular models, making it a candidate for research in neurodegenerative diseases and age-related oxidative stress conditions. Its ability to modulate signaling pathways such as NF-κB suggests possible applications in reducing chronic inflammation. Additionally, Fragransin A2 has exhibited mild antimicrobial properties against select bacterial strains, which could support its use in developing natural antimicrobial agents. Due to its structural complexity and bioactivity, it is also used as a lead compound in the synthesis of derivatives for drug discovery.